Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. (Q40575888)
Jump to navigation
Jump to search
scientific article published on May 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. |
scientific article published on May 2002 |
Statements
Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial (English)
W Tad Archambault
Linda Moore
Ron Marchesani
Jason Tian
Robert E Shope
Nicola Thomas
Robert Schrader
Dean Furby
Philip Bedford
Thomas P Monath